Narcotics

• 

  Subject Areas on Research

  • A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice. 
  • A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics. 
  • Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD). 
  • Acute changes in cranial blood flow after cocaine hydrochloride. 
  • Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction. 
  • Advances in the pharmacological management of breathlessness. 
  • Alterations in baseline activity and quinpirole sensitivity in putative dopamine neurons in the substantia nigra and ventral tegmental area after withdrawal from cocaine pretreatment. 
  • Anaphylactic and anaphylactoid reactions. A review. 
  • Ancient and recent positive selection transformed opioid cis-regulation in humans. 
  • Antagonist treatment of opioid withdrawal translational low dose approach. 
  • Application of continuous incisional infusion of local anesthetic after major pediatric urological surgery. 
  • Behavioral assessment of narcotic detoxification fear. 
  • CSF distribution of opioids in animals and man. 
  • Cholinergic synaptic signaling mechanisms underlying behavioral teratogenicity: effects of nicotine, chlorpyrifos, and heroin converge on protein kinase C translocation in the intermedial part of the hyperstriatum ventrale and on imprinting behavior in an avian model. 
  • Chronic very low dose naltrexone administration attenuates opioid withdrawal expression. 
  • Commentaries on Viewpoint: Why do some patients stop breathing after taking narcotics? Ventilatory chemosensitivity as a predictor of opioid-induced respiratory depression. 
  • Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. 
  • Early outcomes following low dose naltrexone enhancement of opioid detoxification. 
  • Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression. 
  • Effects of low-dose morphine on perceived sleep quality in patients with refractory breathlessness: A hypothesis generating study. 
  • Effects of sex and gonadectomy on cocaine metabolism in the rat. 
  • Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. 
  • Elevated mu-opioid receptor expression in the nucleus of the solitary tract accompanies attenuated withdrawal signs after chronic low dose naltrexone in opiate-dependent rats. 
  • G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice. 
  • Grading the severity of chronic pain. 
  • Guidelines for endoscopy in pregnant and lactating women. 
  • HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users. 
  • How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions. 
  • Imagery reduces children's post-operative pain. 
  • Impact of staged InterStim implantation on the postoperative activities of daily living and pain. 
  • Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study. 
  • Last Word on Viewpoint: Why do some patients stop breathing after taking narcotics? Ventilatory chemosensitivity as a predictor of opioid-induced respiratory depression. 
  • Minimally invasive microendoscopy-assisted transforaminal lumbar interbody fusion with instrumentation. 
  • Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment. 
  • Narcotic use and misuse in Crohn's disease. 
  • Neural grafting reverses prenatal drug-induced alterations in hippocampal PKC and related behavioral deficits. 
  • Neurobehavioral damage to cholinergic systems caused by prenatal exposure to heroin or phenobarbital: cellular mechanisms and the reversal of deficits by neural grafts. 
  • Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. 
  • Ontogeny of the behavioral response to dopamine agonists after chronic cocaine. 
  • Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose. 
  • Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. 
  • Opiates, intracranial pressure, and autoregulation. 
  • Opioid-mediated facilitation of long-term potentiation at the lateral perforant path-dentate granule cell synapse. 
  • Partial cardiopulmonary bypass for core rewarming in profound accidental hypothermia. 
  • Perinatal effects of drugs of abuse. 
  • Postoperative Pain Scores and Narcotic Use in Robotic-assisted Versus Laparoscopic Hysterectomy for Endometrial Cancer Staging. 
  • Postoperative nausea and vomiting. A retrospective analysis in patients undergoing elective craniotomy. 
  • Potentiated opioid analgesia in norepinephrine transporter knock-out mice. 
  • Practical aspects of MAO inhibitor therapy. 
  • Preoperative lumbar epidural morphine improves postoperative analgesia and ventilatory function after transsternal thymectomy in patients with myasthenia gravis. 
  • Preventing and treating acute gout attacks across the clinical spectrum: a roundtable discussion. 
  • Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. 
  • Reader questions benefit of nebulized opioids. 
  • Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. 
  • Role of noradrenergic hyperactivity in neonatal opiate abstinence. 
  • Serendipitous rapid detoxification from opiates: the importance of time-dependent processes. 
  • Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. 
  • Targeting microglial purinergic signaling to improve morphine analgesia. 
  • The kindling model of epilepsy: a critical review. 
  • The medullary dorsal horn: a target for the expression of opiate effects on the perceived intensity of noxious heat. 
  • Treatment considerations for elderly and frail patients with neuropathic pain. 
  • Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: possible site of opiate-CCK analgesic interactions. 
  • US primary care physicians' opinions about conscientious refusal: a national vignette experiment. 
  • Use of very low-dose naltrexone during opiate detoxification. 
  • Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study. 
  • Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. 
  • Why does social exclusion hurt? The relationship between social and physical pain. 
  • [Nphe1]nociceptin(1-13)-NH2 antagonizes nociceptin-induced hypotension, bradycardia, and hindquarters vasodilation in the anesthetized rat. 
• 

  Keywords of People

  • Warner, David Samuel, Distinguished Professor of Anesthesiology, in the School of Medicine, Neurobiology
  • Wray, Gregory Allan, Professor of Biology, Duke Innovation & Entrepreneurship
  • Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine